|Bid||11.65 x 300|
|Ask||11.75 x 600|
|Day's Range||11.55 - 11.70|
|52 Week Range||6.74 - 12.75|
|PE Ratio (TTM)||38.24|
|Earnings Date||Jul 12, 2017 - Jul 17, 2017|
|Dividend & Yield||0.20 (1.70%)|
|1y Target Est||13.35|
Simulations Plus, Inc. , the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development from the earliest discovery through all phases of clinical trials, announced today that Walt Woltosz, chairman and chief executive officer, will present at the Needham Emerging Technology Conference on Wednesday, May 17, 2017, at 12:50 p.m.
Simulations Plus, Inc. , a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that it has entered into a Stock Purchase Agreement with DILIsym Services, Inc.
Simulations Plus, Inc. , a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that Dr. Daniel Weiner, an expert on pharmacokinetic modeling and pharmacodynamics, has become a member of its Board of Directors effective today, filling the vacancy created when Dr.